The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Regression Models for Categorical and Limited Dependent Variables.
MTW, & Long, J. S. (1997) · Journal of the American Statistical Association · doi:10.2307/2965458 · Cited by 6,898
Regression Models for Categorical and Limited Dependent Variables
Calvin, J. A. (1998) · Technometrics · doi:10.1080/00401706.1998.10485496 · Cited by 5,201
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Gardner, W. P., Mulvey, E. P., & Shaw, E. C. (1995) · Psychological Bulletin · doi:10.1037//0033-2909.118.3.392 · Cited by 1,836
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Random group effects and the precision of regression estimates
Moulton, B. R. (1986) · Journal of Econometrics · doi:10.1016/0304-4076(86)90021-7 · Cited by 1,626
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Persistence of Use of Lipid-Lowering Medications: A Cross-National Study
Avorn, J., Monette, J., Lacour, A., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 634
Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Effect of Improved Glycemic Control on Health Care Costs and Utilization
Wagner, E. H. (2001) · JAMA · doi:10.1001/jama.285.2.182 · Cited by 536
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Goldman, D. P. (2004) · JAMA · doi:10.1001/jama.291.19.2344 · Cited by 530
Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06234-x · Cited by 507
Resnick, H. E., Foster, G. L., Bardsley, J., & Ratner, R. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1254 · Cited by 428
The association between diabetes metabolic control and drug adherence in an indigent population
Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1015 · Cited by 373
Patient Adherence Improves Glycemic Control
Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El-Kebbi, I. M., Gallina, D. L., Barnes, C., & Phillips, L. S. (2005) · The Diabetes Educator · doi:10.1177/0145721705274927 · Cited by 339
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
Currie, C. J., Morgan, C. L., Poole, C. D., Sharplin, P., Lammert, M., & McEwan, P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115757 · Cited by 279
Korytkowski, M., Bell, D., Jacobsen, C., Suwannasari, R., & FlexPen® Study Team (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80337-5 · Cited by 267
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
Gaster, B., & Hirsch, I. B. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.134 · Cited by 228
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1873 · Cited by 217
Potential Short-Term Economic Benefits of Improved Glycemic Control
Menzin, J., Langley-Hawthorne, C., Friedman, M., Boulanger, L., & Cavanaugh, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.51 · Cited by 176
Graff, M. R., & McClanahan, M. A. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80058-1 · Cited by 149
Management of Type 2 Diabetes in the Primary Care Setting: A Practice-Based Research Network Study
Spann, S. J. (2006) · The Annals of Family Medicine · doi:10.1370/afm.420 · Cited by 147
Preference for insulin delivery systems among current insulin users and nonusers
SUMMERS, K., Szeinbach, S. L., & Lenox, S. M. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.09.009 · Cited by 127
(2006) · PubMed · Cited by 123
FlexPen®: Addressing issues of confidence andconvenience in insulin delivery
Korytkowski, M. T., NISKANEN, L. K., & Asakura, T. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.019 · Cited by 120
(2004) · PubMed · Cited by 119
Rubin, R. R., & Peyrot, M. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2495 · Cited by 119
Cost of Hypoglycemia in Patients with Type 2 Diabetes in Sweden
Jönsson, L., Bolinder, B., & Lundkvist, J. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00100.x · Cited by 114
Kadiri, A., Chraibi, A., Marouan, F. F., Ababou, M. R., Guermai, N. E., Wadjinny, A., Kerfati, A., Douiri, M., Bensouda, J., Belkhadir, J., et al. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00055-2 · Cited by 97
Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program
Li, J., McCombs, J. S., & Stimmel, G. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00394-9 · Cited by 87
Negotiating the Barrier of Hypoglycemia in Diabetes
Cryer, P. E., & Childs, B. P. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.20 · Cited by 68
Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues
Rolla, A. R., & Rakel, R. E. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.07.003 · Cited by 49
Before oral agents fail: the case for starting insulin early
Marre, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802174 · Cited by 44
The economic effect of hypoglycemia in a health plan.
Heaton, A. H., Martin, S., & Brelje, T. (2003) · PubMed · Cited by 39
Krasuski, R. A., Doeppenschmidt, D., Henry, J. S., Smith, P. B., Adinaro, J. T., Beck, R. L., & Thompson, C. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1163 · Cited by 25
Controlling hypoglycemia in type 2 diabetes: which agent for which patient?
Cefalu, C. A., & Cefalu, W. T. (2005) · PubMed · Cited by 14
Cited by
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407
Davies, M. J., Gagliardino, J. J., Gray, L. J., Khunti, K., Mohan, V., & Hughes, R. (2013) · Diabetic Medicine · doi:10.1111/dme.12128 · Cited by 294
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135
Insulin adherence in patients with diabetes: risk factors for injection omission
Farsaei, S., Radfar, M., Heydari, Z., Abbasi, F., & Qorbani, M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.03.001 · Cited by 106
Guerci, B., Chanan, N., Kaur, S., Jasso-Mosqueda, J. G., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0590-x · Cited by 106
Metadata
- Authors
- Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 28
- Issue
- 10
- Pages
- 1712-1725
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2036845531
- Cited by
- 266
- References
- 42
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.